|
1
|
Yamaguchi M and Yamamoto T: Purification
of calcium binding substance from soluble fraction of normal rat
liver. Chem Pharm Bull (Tokyo). 26:1915–1918. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamaguchi M and Mori S: Effect of
Ca2+and Zn2+on 5′-nucleotidase activity in
rat liver plasma membranes: hepatic calcium-binding protein
(regucalcin) reverses the Ca2+effect. Chem Pharm Bull
(Tokyo). 36:321–325. 1988.
|
|
3
|
Yamaguchi M: A novel
Ca2+-binding protein regucalcin and calcium inhibition.
Regulatory role in liver cell function. Calcium Inhibition. Kohama
K: Japan Sci Soc Press, Tokyo and CRC Press; Boca Raton: pp. 19–41.
1992
|
|
4
|
Shimokawa N and Yamaguchi M: Molecular
cloning and sequencing of the cDNA coding for a calcium-binding
protein regucalcin from rat liver. FEBS Lett. 327:251–255. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shimokawa N, Matsuda Y and Yamaguchi M:
Genomic cloning and chromosomal assignment of rat regucalcin gene.
Mol Cell Biochem. 151:157–163. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiselton DL, McDowall J, Brandau O,
Ramser J, d’Esposito F, Bhattacharya SS, Ross MT, Hardcastle AJ and
Meindl A: An integrated, functionally annotated gene map of the
DXS8026-ELK1 interval on human Xp11.3-Xp11.23: Potential hotspot
for neurogenetic disorders. Genomics. 79:560–572. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Misawa H and Yamaguchi M: The gene of
Ca2+-binding protein regucalcin is highly conserved in
vertebrate species. Int J Mol Med. 6:191–196. 2000.
|
|
8
|
Yamaguchi M: The transcriptional
regulation of regucalcin gene expression. Mol Cell Biochem.
346:147–171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamaguchi M: Novel protein RGPR-p117: its
role as the regucalcin gene transcription factor. Mol Cell Biochem.
327:53–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamaguchi M: Role of regucalcin in calcium
signaling. Life Sci. 66:1769–1780. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamaguchi M: Role of regucalcin in
maintaining cell homeostasis and function (Review). Int J Mol Med.
15:371–389. 2005.PubMed/NCBI
|
|
12
|
Yamaguchi M: Regucalcin and cell
regulation: role as a supressor protein in signal transduction. Mol
Cell Biochem. 353:101–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamaguchi M: Suppressive role of
regucalcin in liver cell proliferation: involvement in
carcinogenesis. Cell Prolif. 46:243–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamaguchi M: The anti-apoptotic effect of
regucalcin is mediated through multisignaling pathways. Apoptosis.
18:1145–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi M: Regucalcin: Genomics, Cell
Regulation and Diseases. Nova Science Publishers, Inc; New York,
NY: 2012
|
|
16
|
Yamaguchi M: Role of regucalcin in cell
nuclear regulation: involvement as a transcription factor. Cell
Tissue Res. 354:331–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Langer GA: Calcium and the heart: exchange
at the tissue, cell and organelle levels. FASEB J. 6:893–902.
1992.PubMed/NCBI
|
|
18
|
Thastrup O, Culler PJ, Drobak BK, Hanley
MR and Dawson AP: Thapsigargin, a tumor promoter, discharges
intracellular Ca2+stores by specific inhibition of the
endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci
USA. 87:2466–2470. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tada M and Kadoma M: Regulation of the
Ca2+pump ATPase by cAMP-dependent phosphorylation of
phospholamban. Bioessays. 10:157–163. 1989.
|
|
20
|
Yamaguchi M and Nakajima R: Role of
regucalcin as an activator of sarcoplasmic reticulum
Ca2+-ATPase activity in rat heart muscle. J Cell
Biochem. 86:184–193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akhter T, Sawada N and Yamaguchi M:
Regucalcin increases Ca2+-ATPase activity in the heart
mitochondria of normal and regucalcin transgenic rats. Int J Mol
Med. 18:171–176. 2006.
|
|
22
|
Yamaguchi M, Isogai M, Kato S and Mori S:
Immunohistochemical demonstration of calcium-binding protein
regucalcin in the tissues of rats: the protein localizes in liver
and brain. Chem Pharm Bull (Tokyo). 39:1601–1603. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamaguchi M and Isogai M: Tissue
concentration of calcium-binding protein regucalcin in rats by
enzyme-linked immunoadsorbent assay. Mol Cell Biochem. 122:65–68.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Misawa H and Yamaguchi M: Indentification
of transcription factor in the promoter region of rat regucalcin
gene: binding of nuclear factor I-A1 to TTGGC motif. J Cell
Biochem. 84:795–802. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Misawa H and Yamaguchi M: Molecular
cloning and sequencing of the cDNA coding for a novel regucalcin
gene promoter region-related protein in rat, mouse and human liver.
Int J Mol Med. 8:513–520. 2001.PubMed/NCBI
|
|
26
|
Akhter T, Nakagawa T, Kobayashi A and
Yamaguchi M: Suppression of regucalcin mRNA expression in the
hearts of rats administered with free radical compound: The
administreation-induced death is accelerated in regucalcin
transgenic rats. Int J Mol Med. 19:653–658. 2007.PubMed/NCBI
|
|
27
|
Doran P, Dowling P, Donoghue P, Buffini M
and Ohlendieck K: Reduced expression of regucalcin in young and
aged mdx diaphragm indicates abnormal cytosolic calcium handling in
dystrophin-deficient muscle. Biochim Biophys Acta. 1764:773–785.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng H, Smith GL, Hancox JC and Orchard
CH: Inhibition of spontaneous activity of rabbit atrioventricular
node cells by KB-R7943 and inhibitors of sarcoplasmic reticulum
Ca2+ATPase. Cell Calcium. 49:56–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marks AR: Calcium cycling proteins and
heart failure: mechanisms and therapeutics. J Clin Invest.
123:46–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamaguchi M, Morooka Y, Misawa H,
Tsurusaki Y and Nakajima R: Role of endogenous regucalcin in
transgenic rats: suppression of kidney cortex cytosolic protein
phosphatase activity and enhancement of heart muscle microsomal
Ca2+-ATPase activity. J Cell Biochem. 86:520–529. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai P, Yip NC and Michelangeli F:
Regucalcin (RGN/SMP30) alters agonist- and thapsigargin-induced
cytosolic [Ca2+] transients in cells by increasing SERCA
Ca2+ATPase levels. FEBS Lett. 585:2291–2294.
2011.PubMed/NCBI
|
|
32
|
Hunter T: Protein kinases and
phosphatases: the Yin and Yang of protein phosphorylation and
signaling. Cell. 80:225–236. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pallen CJ and Wang JH:
Calmodulin-stimulated dephosphorylation of p-nitrophenyl phosphate
and free phosphotyrosine by calcineurin. J Biol Chem.
258:8550–8553. 1983.PubMed/NCBI
|
|
34
|
Molkentin JD, Lu JR, Antos CL, Markham B,
Richardson J, Robbins J, Grant SR and Olson EN: A
calcineurin-dependent transcriptional pathway for cardiac
hypertrophy. Cell. 93:215–228. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ichikawa E, Tsurusaki Y and Yamaguchi M:
Suppressive effect of regucalcin on protein phosphatase activity in
the heart cytosol of normal and regucalcin transgenic rats. Int J
Mol Med. 13:289–293. 2004.PubMed/NCBI
|
|
36
|
Ma ZJ and Yamaguchi M: Suppressive role of
endogenous regucalcin in the regulation of nitric oxide synthase
activity in heart muscle cytosol of normal and regucalcin
transgenic rats. Int J Mol Med. 10:761–766. 2002.PubMed/NCBI
|
|
37
|
Van Remmen H, Williams MD, Guo Z, Estlack
L, Yang H, Carlson EJ, Epstein CJ, Huang TT and Richardson A:
Knockout mice heterozygous for Sod2 show alterations in cardiac
mitochondrial function and apoptosis. Am J Physol Heart Circ
Physiol. 281:H1422–H1432. 2001.PubMed/NCBI
|
|
38
|
den Hartog GJ, Haenen GR, Boven E, van der
Vijgh WJ and Bast A: Lecithinized copper, zinc-superoxide dismutase
as a protector against dexorubicin-induced cardiotoxicity in mice.
Toxicol Appl Pharmacol. 194:180–188. 2004.PubMed/NCBI
|
|
39
|
Adler A, Messina E, Sherman B, Wang Z,
Huang H, Linke A and Hintze TH: NAD(P)H oxidase-generated
superoxide anion accounts for reduced control of myocardial
O2consumption by NO in old Fisher 344 rats. Am J Physiol
Heart Circ Physiol. 285:H1015–H1022. 2003.PubMed/NCBI
|
|
40
|
Ichikawa E and Yamaguchi M: Regucalcin
increases superoxide dismutase activity in the heart cytosol of
normal and regucalcin transgenic rats. Int J Mol Med. 14:691–695.
2004.PubMed/NCBI
|
|
41
|
Misaka T, Suzuki S, Miyata M, Kobayashi A,
Shishido T, Ishigami A, Saitoh S, Hirose M, Kubota I and Takeishi
Y: Deficiency of senescence marker protein 30 exacerbates
angiotensin II-induced cardiac remodelling. Cardiovasc Res.
99:461–470. 2013. View Article : Google Scholar : PubMed/NCBI
|
